Document is current

Any future updates will be listed below

Leveraging programmed cell death signature to predict clinical outcome and immunotherapy benefits in postoperative bladder cancer

Crossref DOI link: https://doi.org/10.1038/s41598-024-73571-w

Published Online: 2024-10-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark